|
...and the stock lifted8.5 % on Friday. Canadian biotechnology company ProMetic Life Sciences is developing a drug ( PBI-1402 ) for the intervention of anaemia. `` The company recently demonstrated positive Stage...and with patent expiries coming closer, more drug acquisitions should be anticipated and farther ...2008. The marketplace for all anaemia intervention drugs is valued at USA $ ...

http://ag1466.livejournal.com/1903.html
(Cached)
3 links
Published: 2 months, 3 weeks ago (Sat, 18 Apr 2009 21:03:20 PDT); 4682 bytes
|